Cargando…

Initiation and completion rates of isoniazid preventive therapy among people living with HIV in Far-Western Region of Nepal: a retrospective cohort study

OBJECTIVES: Isoniazid preventive therapy (IPT), for people living with HIV (PLHIV) is the proven and recommended intervention to avert tuberculosis (TB). In 2015, Nepal implemented 6 months of IPT for all PLHIV registered for HIV care in antiretroviral therapy (ART) centres. After programmatic imple...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhungana, Govinda Prasad, Thekkur, Pruthu, Chinnakali, Palanivel, Bhatta, Usha, Pandey, Basudev, Zhang, Wei-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549711/
https://www.ncbi.nlm.nih.gov/pubmed/31147370
http://dx.doi.org/10.1136/bmjopen-2019-029058
_version_ 1783424066444591104
author Dhungana, Govinda Prasad
Thekkur, Pruthu
Chinnakali, Palanivel
Bhatta, Usha
Pandey, Basudev
Zhang, Wei-Hong
author_facet Dhungana, Govinda Prasad
Thekkur, Pruthu
Chinnakali, Palanivel
Bhatta, Usha
Pandey, Basudev
Zhang, Wei-Hong
author_sort Dhungana, Govinda Prasad
collection PubMed
description OBJECTIVES: Isoniazid preventive therapy (IPT), for people living with HIV (PLHIV) is the proven and recommended intervention to avert tuberculosis (TB). In 2015, Nepal implemented 6 months of IPT for all PLHIV registered for HIV care in antiretroviral therapy (ART) centres. After programmatic implementation, there has been no systematic assessment of IPT initiation and completion rates among PLHIV. We aimed to assess IPT initiation and completion rates in the Far-Western Region (FWR) of Nepal. DESIGN: We conducted a retrospective cohort study using secondary data extracted from registers maintained at ART centres. SETTING: All 11 ART centres in the FWR of Nepal. PARTICIPANTS: All PLHIV registered for care between January 2016 and December 2017 in 11 ART centres. PRIMARY OUTCOME MEASURES: IPT initiation and completion rates were summarised as percentages with 95% CI. Independent association between patient characteristics and non-initiation of IPT was assessed using cluster-adjusted generalised linear model (log binomial regression) and adjusted relative risk (RR) with 95% CI was calculated. RESULT: Of the 492 PLHIV included, 477 (97.0%) did not have active TB at registration. Among 477 without active TB, 141 (29.8%, 95% CI 25.7% to 34.1%) had been initiated on IPT and 85 (17.8%) were initiated within 3 months of registration. Of 141 initiated on IPT, 133 (94.3%, 95% CI 89.1% to 97.5%) had completed 6 months of IPT. Being more than 60 years of age (RR-1.3, 95% CI 1.1 to 1.7), migrant worker (RR-1.3, 95% CI 1.1 to 1.4) and not being initiated on ART (RR-1.4, 95% CI 1.1 to 1.8) were significantly associated with IPT initiation. CONCLUSIONS: In FWR of Nepal, three out of 10 eligible PLHIV had received IPT. Among those who have received IPT, the completion rate was good. The HIV care programme needs to explore the potential reasons for this low coverage and take context specific corrective action to fix this gap.
format Online
Article
Text
id pubmed-6549711
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-65497112019-06-21 Initiation and completion rates of isoniazid preventive therapy among people living with HIV in Far-Western Region of Nepal: a retrospective cohort study Dhungana, Govinda Prasad Thekkur, Pruthu Chinnakali, Palanivel Bhatta, Usha Pandey, Basudev Zhang, Wei-Hong BMJ Open HIV/AIDS OBJECTIVES: Isoniazid preventive therapy (IPT), for people living with HIV (PLHIV) is the proven and recommended intervention to avert tuberculosis (TB). In 2015, Nepal implemented 6 months of IPT for all PLHIV registered for HIV care in antiretroviral therapy (ART) centres. After programmatic implementation, there has been no systematic assessment of IPT initiation and completion rates among PLHIV. We aimed to assess IPT initiation and completion rates in the Far-Western Region (FWR) of Nepal. DESIGN: We conducted a retrospective cohort study using secondary data extracted from registers maintained at ART centres. SETTING: All 11 ART centres in the FWR of Nepal. PARTICIPANTS: All PLHIV registered for care between January 2016 and December 2017 in 11 ART centres. PRIMARY OUTCOME MEASURES: IPT initiation and completion rates were summarised as percentages with 95% CI. Independent association between patient characteristics and non-initiation of IPT was assessed using cluster-adjusted generalised linear model (log binomial regression) and adjusted relative risk (RR) with 95% CI was calculated. RESULT: Of the 492 PLHIV included, 477 (97.0%) did not have active TB at registration. Among 477 without active TB, 141 (29.8%, 95% CI 25.7% to 34.1%) had been initiated on IPT and 85 (17.8%) were initiated within 3 months of registration. Of 141 initiated on IPT, 133 (94.3%, 95% CI 89.1% to 97.5%) had completed 6 months of IPT. Being more than 60 years of age (RR-1.3, 95% CI 1.1 to 1.7), migrant worker (RR-1.3, 95% CI 1.1 to 1.4) and not being initiated on ART (RR-1.4, 95% CI 1.1 to 1.8) were significantly associated with IPT initiation. CONCLUSIONS: In FWR of Nepal, three out of 10 eligible PLHIV had received IPT. Among those who have received IPT, the completion rate was good. The HIV care programme needs to explore the potential reasons for this low coverage and take context specific corrective action to fix this gap. BMJ Publishing Group 2019-05-29 /pmc/articles/PMC6549711/ /pubmed/31147370 http://dx.doi.org/10.1136/bmjopen-2019-029058 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle HIV/AIDS
Dhungana, Govinda Prasad
Thekkur, Pruthu
Chinnakali, Palanivel
Bhatta, Usha
Pandey, Basudev
Zhang, Wei-Hong
Initiation and completion rates of isoniazid preventive therapy among people living with HIV in Far-Western Region of Nepal: a retrospective cohort study
title Initiation and completion rates of isoniazid preventive therapy among people living with HIV in Far-Western Region of Nepal: a retrospective cohort study
title_full Initiation and completion rates of isoniazid preventive therapy among people living with HIV in Far-Western Region of Nepal: a retrospective cohort study
title_fullStr Initiation and completion rates of isoniazid preventive therapy among people living with HIV in Far-Western Region of Nepal: a retrospective cohort study
title_full_unstemmed Initiation and completion rates of isoniazid preventive therapy among people living with HIV in Far-Western Region of Nepal: a retrospective cohort study
title_short Initiation and completion rates of isoniazid preventive therapy among people living with HIV in Far-Western Region of Nepal: a retrospective cohort study
title_sort initiation and completion rates of isoniazid preventive therapy among people living with hiv in far-western region of nepal: a retrospective cohort study
topic HIV/AIDS
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549711/
https://www.ncbi.nlm.nih.gov/pubmed/31147370
http://dx.doi.org/10.1136/bmjopen-2019-029058
work_keys_str_mv AT dhunganagovindaprasad initiationandcompletionratesofisoniazidpreventivetherapyamongpeoplelivingwithhivinfarwesternregionofnepalaretrospectivecohortstudy
AT thekkurpruthu initiationandcompletionratesofisoniazidpreventivetherapyamongpeoplelivingwithhivinfarwesternregionofnepalaretrospectivecohortstudy
AT chinnakalipalanivel initiationandcompletionratesofisoniazidpreventivetherapyamongpeoplelivingwithhivinfarwesternregionofnepalaretrospectivecohortstudy
AT bhattausha initiationandcompletionratesofisoniazidpreventivetherapyamongpeoplelivingwithhivinfarwesternregionofnepalaretrospectivecohortstudy
AT pandeybasudev initiationandcompletionratesofisoniazidpreventivetherapyamongpeoplelivingwithhivinfarwesternregionofnepalaretrospectivecohortstudy
AT zhangweihong initiationandcompletionratesofisoniazidpreventivetherapyamongpeoplelivingwithhivinfarwesternregionofnepalaretrospectivecohortstudy